Yes, nanotechnology holds significant promise for gene therapy. Nanoparticles can be used to deliver genetic material such as DNA or RNA to target cells, enabling the correction of genetic disorders. This method offers advantages over viral vectors, including reduced immunogenicity and the ability to carry larger genetic payloads. CRISPR-Cas9 systems, for example, can be delivered using nanocarriers, offering a precise tool for gene editing.
